Startups

Aindo
Trieste, Italy · Milan, Italy
Aindo S.p.A. is a Trieste, Italy artificial-intelligence company founded in2018 from SISSA research. Its official legal footer identifies VAT01313960328, REA TS203253 and registered address LocalitàPadriciano99; historical AindoSrl and currentSpA represent the same source-qualified business. Aindo develops generative-AI synthetic-data technology that models statistical characteristics of sensitive datasets for research and data sharing. Its current healthcare work includes real-world evidence, synthetic external control arms, public-health planning and specialised clinical language models; it also serves finance and public-sector users. These are AI/data infrastructure applications, without an inferred neuroscience therapy approval or proof of clinical efficacy. The company reports Europrivacy and ISO certifications; product privacy and regulatory statements are attributed to company publications. Its current native official directory publishes29 people across executives, scientific/regulatory, machine learning, privacy research, data science, engineering, commercial, people, finance and operations functions. Cofounders DanielePanfilo and SebastianoSaccani remain listed; third cofounder BorutSvara’s CTO affiliation is documented inOctober2023 and distinguished from current CTOSimoneZiraldo. Actual disclosed equity financing is EUR2.8M from managed VertisVenture3TechnologyTransfer announcedNovember30,2021 and EUR6M SeriesA closedOctober18,2023 led byUnitedVentures withVertis follow-on. The2021–2022timeline’s EUR3M rounded historical investment is not added as a new round. Public research awards and expressly received grants are recorded separately: EU SydAi grant agreement101218531 was signedJune20,2025 with exact contributionEUR2,080,085.71, rounded by thecompany to2.1M. Signing/projectstart/award announcements do not prove completed cash disbursement; possible EIB co-investment is not an actual equity cheque. FVG historical cash grants and other programme awards are distinguished from eligible project costs and budget shares. Nominal paid-in share capitalEUR88,105 is not financing. Commercial/customer and research collaborations are not inferred equity investments.
Founded 2018




























